EchoSolv AS vs inHEART Models

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

EchoSolv AS

by Echo IQ

inHEART Models

by inHEART

AI Verdict

EchoSolv AS is designed for early identification and risk assessment of severe aortic stenosis using echocardiogram data, providing clinical decision support. In contrast, inHEART Models focuses on creating detailed 3D heart models from CT/MR images to optimize the planning and execution of cardiac ablation procedures. While both are cardiology AI tools, they serve distinct purposes within the patient care pathway: diagnosis and risk stratification versus pre-procedural planning for intervention.

Choose EchoSolv AS if…

Choose EchoSolv AS if your primary goal is to efficiently and accurately identify patients at high risk for severe aortic stenosis directly from echocardiogram measurements. This tool is ideal for cardiology departments seeking to streamline their clinical decision support workflow, prioritize studies for closer review, and ensure consistent risk assessment without requiring EMR integration.

View EchoSolv AS →

Choose inHEART Models if…

Choose inHEART Models if you require highly detailed, AI-driven 3D digital twin models of the heart for advanced pre-procedural planning and optimization of image-guided cardiac ablation procedures. This solution is best suited for electrophysiology labs aiming to enhance precision, potentially reduce procedure times, and improve outcomes for complex ablations by leveraging comprehensive anatomical insights from CT/MR images.

View inHEART Models →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	EchoSolv AS	inHEART Models
Pricing	Unknown	Contact for pricing
Deployment	Cloud-based	Cloud-based
BAA Available	Yes AI-estimated	Unknown
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

EchoSolv AS

EchoSolv AS (Tool A) emphasizes ease of integration with existing PACS and no EMR integration required, alongside ultra-fast risk detection (under 3 seconds). This suggests a streamlined workflow and immediate feedback for clinicians. While inHEART Models (Tool B) integrates with EAM systems, its interactive 3D models likely involve a more intensive, though valuable, user interaction for procedural planning.

Clinical Value

inHEART Models

Both tools are FDA-cleared and address critical cardiology needs. However, inHEART Models (Tool B) provides quantifiable potential benefits, claiming to reduce VT procedure times by 60% and recurrence rates by 38%. These specific, measurable improvements in patient outcomes and procedural efficiency demonstrate a high and direct clinical impact, whereas EchoSolv AS (Tool A) focuses on high accuracy and efficiency in identifying severe aortic stenosis risk.

Pricing & Value

Tie

Neither EchoSolv AS (Tool A) nor inHEART Models (Tool B) publicly disclose their pricing, requiring direct contact with the vendor for details. Without transparent pricing or detailed, comparative cost-effectiveness studies for both, it is not possible to determine a winner in this dimension.

Enterprise Readiness

EchoSolv AS

EchoSolv AS (Tool A) explicitly states it is HIPAA compliant and has a Business Associate Agreement (BAA). While inHEART Models (Tool B) is FDA-cleared and SOC2 compliant, suggesting strong data security, its HIPAA compliance and BAA readiness are inferred rather than explicitly stated. Tool A's explicit compliance statements offer clearer assurance for enterprise adoption.

Innovation

inHEART Models

inHEART Models (Tool B) offers an 'AI-driven digital twin of the heart' for detailed 3D modeling and pre-procedural planning for complex cardiac ablations, representing a transformative approach to surgical planning. While EchoSolv AS (Tool A) uses innovative measurement-based AI for sAS detection, the 'digital twin' concept for procedural optimization appears to be a more groundbreaking innovation in its field.

Support & Docs

Tie

The provided structured facts and web searches did not yield specific details regarding the level of support or documentation available for either EchoSolv AS (Tool A) or inHEART Models (Tool B). Therefore, a definitive comparison cannot be made, resulting in a tie.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	EchoSolv AS	inHEART Models
Name	EchoSolv AS	inHEART Models
Company	Echo IQ	inHEART
Core Functionality	AI-powered clinical decision support to identify patients at risk for severe aortic stenosis.	AI-driven software creating detailed 3D digital twin models of the heart for image-guided cardiac ablation procedures.
Input Data Type	Numerical measurements from echocardiograms (not images)	CT/MR images
Primary Output	Consistent severe AS probability and guideline check from measurements	Highly detailed, interactive 3D cardiac models
Key Integration	Integrates with PACS; designed to fit existing workflows (no EMR integration required)	Seamless integration with major electroanatomic mapping (EAM) systems (Cartou00ae, Rhythmiau2122, Ensiteu2122, Afferau2122)

Videos

Demos, reviews, and walkthroughs featuring EchoSolv AS and inHEART Models.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What are the primary clinical applications of EchoSolv AS and inHEART Models?

EchoSolv AS is an AI-powered clinical decision support platform that analyzes echocardiograms to identify patients at risk for severe aortic stenosis with high accuracy and efficiency. In contrast, inHEART Models is an AI-driven software that creates detailed 3D digital twin models of the heart from CT/MR images, primarily optimizing the planning and execution of image-guided cardiac ablation procedures.

What type of patient imaging data does each tool utilize?

EchoSolv AS uses measurement-based AI, analyzing numerical measurements from echocardiograms to provide severe AS probability and guideline checks. inHEART Models, on the other hand, performs automated segmentation of CT and MR images to create its detailed 3D cardiac models.

How do these tools integrate into existing clinical workflows?

EchoSolv AS is designed to fit existing workflows, integrating with PACS and not requiring EMR integration. inHEART Models offers seamless integration with major electroanatomic mapping (EAM) systems, including Cartou00ae, Rhythmiau2122, Ensiteu2122, and Afferau2122, for use during procedures.

What are the key technological differences in how these tools generate their insights?

EchoSolv AS employs a measurement-based AI that analyzes numerical measurements from echocardiogram reports, rather than images, to provide risk assessment for severe aortic stenosis. Conversely, inHEART Models uses AI-driven automated segmentation of CT and MR images to construct highly detailed, interactive 3D digital twin models of the heart.

What are the compliance and data security assurances for each platform?

EchoSolv AS is FDA-cleared, HIPAA compliant, and has a Business Associate Agreement (BAA). It is also SOC 2 Type II Certified. inHEART Models is FDA-cleared, and while not explicitly stating HIPAA compliance or BAA, its SOC2 compliance suggests a strong focus on data security and privacy.

What specific clinical outcomes or efficiencies are highlighted for each tool?

EchoSolv AS offers ultra-fast risk detection (under 3 seconds) and supports faster clinical review using standardized, measurement-based AI. For inHEART Models, early clinical evaluations have shown the potential to reduce VT procedure times by 60% and reduce VT recurrence rates by 38%.